Immunogenic chemotherapy and immune checkpoint inhibition (ICI) in microsatellite-stable (MSS) metastatic colorectal cancer (mCRC): Biomarkers indicative of durable treatment response.-MedSci.cn

Immunogenic chemotherapy and immune checkpoint inhibition (ICI) in microsatellite-stable (MSS) metastatic colorectal cancer (mCRC): Biomarkers indicative of durable treatment response.

Ree, AH; Meltzer, S; Bakke, KM; Hamre, HM; Kersten, C; Hofsli, E; Guren, MG; Sorbye, H; Johansen, C; Negard, A; Redalen, KR; Flatmark, K

CANCER RESEARCH, 2021; 81 (13):

科室
- - 订阅+
  - 更多科室
工具
服务